高级检索

基于UK Biobank队列中老年人群血尿酸水平和房颤发病风险的关联分析

Association of serum uric acid levels and atrial fibrillation risk in middle-aged and older adults from the UK Biobank cohort

  • 摘要:
    目的 探讨血尿酸水平与房颤累积发病风险的关联,评价不同血尿酸水平对房颤发病的预测价值。
    方法 基于大规模前瞻性流行病学队列UK Biobank,回顾性纳入研究参与者451 879名,年龄40~69岁,中位随访时间为13.6年。依据性别相关的血清尿酸水平四分位数界值(Q1~Q4)与是否确诊高尿酸血症将参与者分组,采用Cox比例风险模型、敏感性分析等方法,对比各组参与者基线数据、随访过程中房颤发病情况。
    结果 基线尿酸水平更高者更倾向为高龄、肥胖、教育水平低、癌症史,且三酰甘油、低密度脂蛋白胆固醇、C反应蛋白水平显著更高,高密度脂蛋白胆固醇水平更低(P<0.001);尿酸最高组糖尿病患病率最高(6.49%)。基线血尿酸水平更高者(log-rank P<0.05)或诊断有高尿酸血症者,房颤的累积发病率显著升高(P<0.001)。调整潜在混杂因素后,与血尿酸Q1水平组相比,血尿酸Q4水平组房颤发病风险增加20%(HR=1.20,95%CI 1.16~1.25),尿酸水平每增加74.7 μmol/L,房颤发病风险增加9%(HR=1.09,95%CI 1.08~1.11)。高尿酸血症患者,房颤发病风险增加20%(HR=1.20,95%CI 1.17~1.24)。尿酸水平与房颤风险呈非线性关联(非线性检验P<0.01),亚组分析提示该危险效应存在显著的亚组异质性,高尿酸血症对女性房颤的致病风险更高。
    结论 血尿酸水平升高可能增加房颤累积发病风险,且该致病效应与年龄、种族、癌症史、体质量指数及性别显著相关。

     

    Abstract:
    Objective To explore the association between serum uric acid levels and the cumulative incidence risk of atrial fibrillation, and to evaluate the predictive value of different uric acid levels for the onset of atrial fibrillation.
    Methods A retrospective selection of 451 879 participants from the large-scale prospective epidemiological cohort UK Biobank, aged 40-69 years, all completed a median follow-up of 13.6 years. Participants were divided into groups based on the interquartile range of serum uric acid levels (Q1–Q4) related to gender and whether they were diagnosed with hyperuricemia. Cox proportional hazards model, sensitivity analysis, and other methods were used to compare baseline data and atrial fibrillation incidence during follow-up among each group of participants.
    Results  Individuals with higher baseline uric acid levels tended to be older, more obese, and had lower education levels and a history of cancer, along with significantly higher levels of triglyceride, low-density lipoprotein cholesterol, and C-reactive protein, but lower high-density lipoprotein cholesterol levels (P<0.001); the highest uric acid group showed the highest diabetes prevalence (6.49%). Participants with higher serum uric acid levels (log-rank P<0.05) or diagnosed with hyperuricemia had significantly higher incidence of atrial fibrillation (P<0.001). After adjusting for potential confounders, compared to Q1 uric acid level group, the Q4 level was associated with a 20% increased risk of atrial fibrillation (HR=1.20, 95%CI 1.16–1.25). Each 74.7 μmol/L increase in uric acid level was associated with a 9% increased incidence risk of atrial fibrillation (HR=1.09, 95%CI 1.08–1.11). Individuals with hyperuricemia had a 20% increased incidence risk of atrial fibrillation (HR=1.20, 95%CI 1.17–1.24). A nonlinear association was observed between uric acid levels and the incidence risk of atrial fibrillation (P for nonlinearity <0.01). Subgroup analysis indicated significant heterogeneity of the risk effect across subgroups, with a higher risk associated with hyperuricemia in females.
    Conclusions Elevated blood uric acid levels may increase the cumulative risk of atrial fibrillation, and this pathogenic effect is significantly correlated with age, race, cancer history, body mass index, and sex.

     

/

返回文章
返回